A commentary on a randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients [1]

Transplantation

Volumn 68, Issue 5, 1999, Pages 708-709

  Korvick, J A ^a   Elashoff, M R ^a   Cavaille Coll, M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; LETTER; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 0033568040     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909150-00020     Document Type: Letter

References (4)